Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adolescent medicine
advances in neurology
Alzheimer's disease
amyloid angiopathy, cerebral
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, childhood
amyotrophic lateral sclerosis, familial
amyotrophic lateral sclerosis, Parkinson-dementia-complex
amyotrophic lateral sclerosis, post-encephalitic
anticholinergic drugs
apraxia of eyelid opening
athetosis
athetosis, causes of
atlanto axial dislocation, congenital
basal ganglia
basal ganglia, degeneration
benign essential tremor
biologic markers
biopterin deficiency
bradykinesia
brain biopsy
cavernous sinus, syndrome
cerebral palsy
cerebrospinal fluid
cerebrospinal fluid, gamma amino butyric acid
children
chorea
chorea, causes of
cogwheel rigidty
degenerative diseases of CNS
dementia
dementia, frontotemporal
dementia, subcortical
differential diagnosis
dopa responsive dystonia
dopamine
dyskinesia
dyskinesia, causes of
dyskinesia, drug induced
dystonia
dystonia musculorum deformens
dystonia, treatment of
electromyogram
encephalocele
epidemiology of neurology
equinovarus
exercise
exercise-induced neurologic dysfunction
extrapyramidal
familial
fasciculation
Friedreich's ataxia
gait disorder
gamma amino butyric acid
gene mutation
genetic neurologic disorders
genetic testing
Gilles de la Tourette syndrome
hemangioma
hepatolenticular degeneration(Wilson's disease)
homovanillic acid
Huntington's chorea
hydroxyindole acetic acid 5(5HIAA)
hypoxic encephalopathy
imbalance
inclusion bodies, intranuclear
infantile tremor syndrome
Jakob-Creutzfeldt disease
L-dopa
Lewy body disease, diffuse
malformation, CNS, congenital
malformation, vascular
malformation, vascular, cerebral
masked facies
mimics
misdiagnosis
molecular genetics
motor neuron disease
motor neuron disease, juvenile form
movement disorder
movement disorder, extrapyramidal
movement disorder, treatment of
MRI, abnormal
MRI, functional
multiple sclerosis
multiple system atrophy
myoclonus
neurologic disease, diagnoses of
neuronal intranuclear inclusion disease
neurotransmitter
ophthalmoplegia
ophthalmoplegia, painful
Parkinson disease
Parkinson disease, drug induced
Parkinson disease, dystonia with
Parkinson disease, juvenile
Parkinson disease, treatment of
Parkinsonism syndrome
peptides, brain
periodic paralysis
periodic paralysis, thyrotoxic
PRKN gene
procyclidine
progressive neurologic disorder
progressive supranuclear palsy
review article
rigidity
running
serotonin
sinemet
spina bifida
spinal muscular atrophy
spinocerebellar ataxia
subacute myelo-opticoneuropathy(S.M.O.N.)complex
subarachnoid hemorrhage
tardive dyskinesia
tardive dyskinesia, treatment of
tardive dystonia
tetrabenazine
toe walking
Tolosa Hunt syndrome
tonic foot response
torticollis
treatment of neurologic disorder
tremor
tremor, postural
trinucleotide repeats
varicella zoster virus
varicella zoster virus, encephalitis
wheelchair
writers cramp
Showing articles 500 to 550 of 1514 << Previous Next >>

Progression of Parkinsonian Signs in Alzheimer's Disease
Neurol 54:1284-1289, Wilson,R.S.,et al, 2000

Botulinum Toxin A as Treatment for Drooling Saliva in PD
Neurol 54:244-247, Pal,P.K.,et al, 2000

Evolution of Sporadic Olivopontocerebellar Atrophy Into Multiple System Atrophy
Neurol 55:527-532, Gilman,S. et al, 2000

Postanoxic Parkinsonism: Clinical, Radiologic, and Pathologic Correlation
Neurol 55:591-593, Li,J.Y. et al, 2000

What Contributes to Quality of Life in Patients with Parkinson's Disease?
JNNP 69:308-312,289, Schrag,A. et al, 2000

Niemann-Pick Disease Type C: Two Cases and an Update
Movement Disorders 15:1199-1203, Uc,E.Y.,et al, 2000

Botulinum Toxin is a Useful Treatment in Excessive Drooling of Saliva
JNNP 67:697, Bhatia,K.P.,et al, 1999

Parkinson Disease in Twins,An Etiologic Study
JAMA 281:341-346,376, Tanner,C.M.,et al, 1999

Clinical Correlates of Vascular Parkinsonism
Arch Neurol 56:98-102, Winikates,J.&Jancovic,J., 1999

Mortality Cancer Risk in Parkinsonian Patients:A Population-Based Study
Neurol 52:395-398, Vanacore,N.,et al, 1999

Long-Term Evaluation of Bilateral Fetal Nigral Transplantation in Parkinson Disease
Arch Neurol 56:179-187, Hauser,R.A.,et al, 1999

Acute and Reversible Parkinsonism Due to Organophosphate Pesticide Intoxication, Five Cases
Neurol 52:1467-1471, Bhatt,M.H.,et al, 1999

Falling Asleep at the Wheel:Motor Vehicle Mishaps in Persons Taking Pramipexole and Ropinirole
Neurol 52:1908-1910, Frucht,S.,et al, 1999

Topiramate in Clinical Practice:First Year's Postlicensing Experience in a Specialist Epilepsy Clinic
JNNP 66:759-763, Kellett,M.W.,et al, 1999

Chronic Subthalamic Nucleus Stimulation Reduces Medication Requirements in Parkinson's Disease
Neurol 53:85-90, Moro,E.,et al, 1999

Transderm-induced Psychosis in Parkinson's Disease
Neurol 53:433-434, Minagar,A.,et al, 1999

Stereotactic Radiosurgical Pallidotomy and Thalamotomy with the Gamma Knife:MR Imaging Findings with Clinical Correlation-Preliminary Experience
Radiology 212:143-150, Friedman,D.P.,et al, 1999

A 3-Year Randomized Trial of Ropinirole and Bromocriptine in Early Parkinson's Disease
Neurol 53:364-370, Korczyn,A.D.,et al, 1999

Zolpidem in Progressive Supranuclear Palsy
NEJM 341:543-544, Daniele,A.,et al, 1999

Comparative Effects of Unilateral and Bilateral Subthalamic Nucleus Deep Brain Stimulation
Neurol 53:561-566, Kumar,R.,et al, 1999

Recent Advances, Neurology
BMJ 319:362-366, Larner,A.J.&Farmer,S.F., 1999

Rapid-Onset Dystonia-Parkinsonism:Linkage to Chromosome 19q13
Ann Neurol 46:176-182, Kramer,P.L.,et al, 1999

Pathologic Heterogeneity in Clinically Diagnosed Corticobasal Degeneration
Neurol 53:795-800, Boeve,B.F.,et al, 1999

Use of Placebo Surgery in Controlled Trials of a Cellular-Based Therapy for Parkinson's Disease
NEJM 341:988-992, Freeman,T.B.,et al, 1999

Stereotactic Pallidotomy in the Treatment of Parkinson Disease,An Expert Opinion
Arch Neurol 56:1064-1069, Bronstein,J.M.,et al, 1999

Immediate-Release and Controlled-Release Carbidopa/Levodopa in PD, A 5-Year Randomized Multicenter Study
Neurol 53:1012-1019, Koller,W.C.,et al, 1999

Progress in Functional Neurosurgery for Parkinson's Disease
Lancet 354:1658-1659,1665, Quinn,N., 1999

Diagnosing Dementia with Lewy Bodies
Lancet 354:1227-1228, McKeith,I.G.,et al, 1999

Bilateral Substantia Nigra Changes on MRI in a Patient with Encephalitis Lethargica
Neurol 53:1860-1862, Kun,L.N.,et al, 1999

Unilateral Pallidotomy for Parkinson's Disease:Results after More Than 1 Year
JNNP 67:511-517, Schrag,A.,et al, 1999

Nuclear Medicine in Neurology and Psychiatry
Lancet 354:1107-1111, Costa,D.C.,et al, 1999

Dementia as the Most Common Presentation of Cortical-Basal Ganglionic Degeneration
Neurol 53:1969-1974, Grimes,D.A.,et al, 1999

Prevalence of Progressive Supranuclear Palsy and Multiple System Atrophy:A Cross-Sectional Study
Lancet 354:1771-1775, Schrag,A.,et al, 1999

Evaluation of Surgery for Parkinson's Disease, A Report of the Therapeutics and Technology Assessment Subcommittee of the AAN
Neurol 53:1910-1921, Hallett,M.,et al, 1999

Dementia Following Treatment of Brain Tumors with Radiotherapy Administered Alone or in Combination with Nitrosourea-Based Chemotherapy: A Clinical and Pathological Study
J Neurooncol 41:137-149, Vigliani,M.C.,et al, 1999

Multicentre European Study of Thalamic Stimulation in Paarkinsonisn and Essential Tremor
JNNP 66:289-296, Limousin,P.,et al, 1999

Course and Treatment of Myasthenia Gravis During Pregnancy
Neurol 52:447-452, Batocchi,A.P.,et al, 1999

Progression of Parkinsonian Signs in Parkinson Disease
Arch Neurol 56:334-337, Louis,E.D.,et al, 1999

Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
NEJM 340:757-763,801, The Parkinson Study Group, 1999

Neurologic Side Effects in Neuroleptic-Naive Patients Treated with Haloperidol or Risperidone
Neurol 52:782-785, Rosebush,P.I.&Mazurek,M.F., 1999

Diagnostic Criteria for Parkinson Disease
Arch Neurol 56:33-39, Gelb,D.J.,et al, 1999

Magnetic Resonance Imaging-Based Volumetry Differentiates Idiopathic Parkinson's Syndrome from Multiple System Atrophy and Progressive Supranuclear Palsy
Ann Neurol 45:65-74, Schulz,J.B.,et al, 1999

Susceptibility to Neuroleptic Malignant Syndrome in Parkinson's Disease
Neurol 52:777-781, Ueda,M.,et al, 1999

Parkinsonism after Taking Ecstasy
NEJM 340:1443, Mintzer,S.,et al, 1999

Transient Acute Depression Induced by High-Frequency Deep-Brain Stimulation
NEJM 340:1476-1480,1500, Bejjani,B-P.,et al, 1999

Clinicopath Conf:Multisystem Neurodegenerative Disease with Dementia Pugilistica
NEJM 340:1269-1277, Case 12-1999, 1999

The Effect of Estrogen Replacement on Early Parkinson's Disease
Neurol 52:1417-1421, Sanders-Pullman,R.,et al, 1999

Prevalence and Clinical Correlates of Psychotic Symptoms in parkinson Disease
Arch Neurol 56:595-601, Aarsland,D.,et al, 1999

Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study
JNNP 66:436-441, Pinter,M.M.,et al, 1999

Delayed Movement Disorders After Carbon Monoxide Poisoning
Eur Neurol 42:141-144, Choi,I.S. &Cheon,H.Y., 1999



Showing articles 500 to 550 of 1514 << Previous Next >>